Skip to main content
AVAHAveanna Healthcare Holdings IncSell6.2·$13.06
SellModerate Confidence
Investment thesis

Aveanna Healthcare has strung together four straight earnings beats with a 118% average positive surprise and trades at a forward price-to-earnings multiple of 9.4 times — but a debt-to-equity ratio of 6.2 and free cash flow converting at only 32% of net income are meaningful structural risks that cap near-term position size.

Thesis pillars

  • Strong Earnings Beat Streak↓Deteriorating
  • Attractive Growth Adjusted Valuation→Stable
  • High Leverage Financial Vulnerability↑Improving
  • +2 more pillars — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Mar 19, 2026

Full reasoning →

Open full analysis

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis

Catalyst-Driven edge

SellVALUE-TRAP 2/5GrowthQualityModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Analyst target reached at $13.06 — A.R:R 0.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Medicare, Medicaid and private health insurance payers.

Aveanna Healthcare is the largest provider of private duty nursing (PDN) services in the United States, operating through three segments: Private Duty Services, Home Health & Hospice, and Medical Solutions. The company has completed and integrated eighteen acquisitions since... Read more

$13.06+0.3% A.UpsideScore 6.2/10#5 of 35 Medical Care Facilities
QualityF-score6 / 9FCF yield3.64%
Stop $12.30Analyst target $13.09(−13% haircut)A.R:R 0.0:1
Analyst consensus$15.05+15.2%10 analysts
$13.09Analyst target
$13.06price
$15.05mean
$16

Sell if holding. Analyst target reached at $13.06 — A.R:R 0.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Medicare, Medicaid and private health insurance payers. Chart setup: No clear chart pattern; technical signals are mixed. Score 6.2/10, moderate confidence.

Passes 3/7 gates (no SEC red flags, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and clean insider activity. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-29
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Nov 12, 202613d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Strong earnings beat streak (3/4)
Attractive valuation
Risks
Concentration risk — Customer: Medicare, Medicaid and private health insurance payers
Analyst target reached - limited upside remaining
V7 low-quality RISK_OFF penalty: -0.5 (Q=5.5)

Key Metrics

P/E (TTM)10.4
P/E (Fwd)14.4
Mkt Cap$2.9B
EV/EBITDA13.6
Profit Mgn10.6%
ROE198.6%
Rev Growth13.7%
Beta1.95
DividendNone
Rating analysts17

Quality Signals

Piotroski F6/9MoatNarrow

Options Flow

P/C0.14bullish
IV113%elevated

Concentration Risks(10-K Item 1A)

  • HIGHCustomerMedicare, Medicaid and private health insurance payers
    10-K Item 1A: 'Third-party payers including Medicare, Medicaid and private health insurance payers provide substantially all funding for our home health and hospice services'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

10 dimensions · all in-band

GatesMomentum 4.3<4.5A.R:R 0.0 < 1.5@spotINSIDER 19.59%=EXTREMEEARNINGS PROXIMITY 13d<=14d (soft)No SEC red flagsSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
64 · Neutral
↑ 20D MA↓ 50D MA↑ 200D MAGOLDEN CROSSSupport $12.00Resistance $13.53

Price Targets

$12
$13
A.Upside+0.3%
A.R:R0.0:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! Target reached (0.3% upside)
! momentum at 4.3 (below the engine's 4.5 threshold)
! asymmetry at 0.0 (below the engine's 1.5 threshold)@spot

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-11-12 (13d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AVAH stock a buy right now?

Sell if holding. Analyst target reached at $13.06 — A.R:R 0.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Medicare, Medicaid and private health insurance payers. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $12.30. Score 6.2/10, moderate confidence.

What is the AVAH stock price target?

Analyst target: $13.09 (+0.3% upside). Prior stop was $12.30. Stop-loss: $12.30.

What are the risks of investing in AVAH?

Concentration risk — Customer: Medicare, Medicaid and private health insurance payers; Analyst target reached - limited upside remaining; V7 low-quality RISK_OFF penalty: -0.5 (Q=5.5).

Is AVAH overvalued or undervalued?

Aveanna Healthcare Holdings Inc trades at a P/E of 10.4 (forward 14.4). TrendMatrix value score: 7.6/10. Verdict: Sell.

What do analysts say about AVAH?

17 analysts cover AVAH with a consensus score of 4.1/5. Average price target: $15.

What does Aveanna Healthcare Holdings Inc do?Aveanna Healthcare is the largest provider of private duty nursing (PDN) services in the United States, operating...

Aveanna Healthcare is the largest provider of private duty nursing (PDN) services in the United States, operating through three segments: Private Duty Services, Home Health & Hospice, and Medical Solutions. The company has completed and integrated eighteen acquisitions since 2017 to build a national home-care platform, with Medicare, Medicaid, and private insurers funding substantially all of its home health and hospice revenue.

Related stocks: SRTA (Strata Critical Medical, Inc.) · ASTH (Astrana Health Inc.) · CHE (Chemed Corp) · THC (Tenet Healthcare Corporation) · STLN (Starling Oncology, Inc.)
Home › Stocks › AVAH

Latest news

Latest News

Yahoo Finance127d ago
Newser162d ago
Seeking Alpha162d agoEarnings
MarketBeat78d ago
Yahoo Finance85d ago
The Globe and Mail148d ago
Yahoo Finance128d ago
Yahoo Finance128d ago
TradingKey128d ago
MSN170d ago
Seeking Alpha149d ago
Simplywall.st126d ago
TradingKey133d ago
TradingKey133d ago
TradingKey133d ago
TradingKey133d ago
TradingKey133d ago
TradingKey133d ago
TradingView84d agoEarnings
GuruFocus147d ago
Loading more...